2020 April ASH 2020 Older myeloma patients can safely undergo an autologous stem cell transplantation and achieve ... Read more
2020 April ASH 2020 The bispecific antibody mosunetuzumab exhibits promising activity in heavily pretreated non-Ho... Read more
2020 April EHA 2019 Frontline brentuximab vedotin + AVD provides durable benefit over ABVD in patients with stage ... Read more
2020 April EHA 2019 Acalabrutinib delays disease progression in patients with relapsed/refractory chronic lymphocy... Read more
2020 April EHA 2019 Voxelotor induces robust improvements in anemia in patients with sickle cell disease Read more
Top
